Ap­peals court re­vers­es No­var­tis win over Re­gen­eron in Eylea-Lu­cen­tis bat­tle

Re­gen­eron on Mon­day suc­cess­ful­ly flipped a low­er court’s de­ci­sion in a hot­ly-con­test­ed case against No­var­tis re­gard­ing the com­pa­nies’ com­pet­ing eye in­jec­tions.

The US Court of Ap­peals for the Sec­ond Cir­cuit in Man­hat­tan backed Re­gen­eron af­ter the com­pa­ny ar­gued that a dis­trict court im­prop­er­ly dis­missed its an­titrust claims, among oth­er ar­gu­ments. The suit, which dates back to Ju­ly 2020, re­lates to com­pe­ti­tion be­tween Re­gen­eron’s block­buster Eylea and No­var­tis’ Lu­cen­tis, both of which are an­ti-VEGF treat­ments.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.